Detalhe da pesquisa
1.
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.
Ann Oncol
; 33(7): 728-738, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339648
2.
Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738].
Ann Oncol
; 34(7): 634, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121856
3.
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
Ann Oncol
; 29(8): 1853-1860, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982279